wpa2015 lecture / symposium

WPA2015 Lecture / Symposium 2015/4/8

Date Room Start End Session Theme RollPresen

No.Given Name Family Name Country Presentation title

6/5 A 1120 1205 Key Note Lecture 2 Chair Helen Herrman Australia

6/5 A 1120 1205 Key Note Lecture 2 Speaker KL2-1 Masatoshi Takeda Japan TBA

6/5 F 0800 0930 Symposium 18 CoordinatorChair

Hironori Kuga Japan

6/5 F 0800 0930 Symposium 18 Co-chair Muneyuki Suzuki Japan

6/5 F 0800 0930 Symposium 18 Speaker1 SY18-1 Muneyuki Suzuki Japan Psychiatric subspecialty training in Japan

6/5 F 0800 0930 Symposium 18 Speaker2 SY18-2 Alexandr Merkin Russia TBA

6/5 F 0800 0930 Symposium 18 Speaker3 SY18-3 Arun Kandasamy India Training in Psychiatric Subspecialties in India

6/5 F 0800 0930 Symposium 18 Speaker4 SY18-4 Li-Te Chiang Taiwan The Training Course of Child and Adolescent Psychiatry in Taiwan

6/5 F 0800 0930 Symposium 18 Speaker5 SY18-5 Hironori Kuga Japan TBA

6/5 F 0800 0930 Symposium 18 Commentator Norman Sartorius Switzerland

6/5 F 0940 1110 Symposium 19 Co-chair Masatoshi Takeda Japan

6/5 F 0940 1110 Symposium 19 Co-chair Winston Shen Taiwan

6/5 F 0940 1110 Symposium 19 Speaker1 SY19-1 Masatoshi Takeda Japan Development and challenges of board certification in Japan (provisional)

6/5 F 0940 1110 Symposium 19 Speaker2 SY19-2 Winston Shen Taiwan The Making of a Subspecialty-certified Psychiatrist in Taiwan

6/5 F 0940 1110 Symposium 19 Speaker3 SY19-3 Pichet Udomratn Thailand Psychiatric Training and Board Certification in Thailand

6/5 F 0940 1110 Symposium 19 Speaker4 SY19-4 Malcolm Hopwood Australia Transparency and due process: a systemic approach to educational decisions and appeals

6/5 F 1120 1205 Special Lecture 4 Chair Michio Suzuki Japan

6/5 F 1120 1205 Special Lecture 4 Speaker SL4-1 Paul Summergrad USA Integrating Care: Mental Health as a Global Imperative


Allan Tasman USA

6/5 F 1425 1555 Symposium 21 Co-chair Pichet Udomratn Thailand

6/5 F 1425 1555 Symposium 21 Speaker1 SY21-1 Michelle Riba USA Integrating Psychiatry into Primary Care and Specialty Care: Models of Training

6/5 F 1425 1555 Symposium 21 Speaker2 SY21-2 Pichet Udomratn Thailand Psychiatric Education in Asia : Opportunities and Challenges

6/5 F 1425 1555 Symposium 21 Speaker3 SY21-3 Allan Tasman USA Competency Based Education and Evaluation in Psychiatry

6/5 F 1425 1555 Symposium 21 Speaker4 SY21-4 Edgard Belfort Venezuela discussant


Tsuyoshi Akiyama Japan

6/5 F 1605 1735 Symposium 26 Co-chair Norman Sartorius Switzerland

6/5 F 1605 1735 Symposium 26 Speaker1 SY26-1 Norman Sartorius Switzerland Depressive disorders in people with diabetes, cardiovascular illness and cancer

6/5 F 1605 1735 Symposium 26 Speaker2 SY26-2 Min-Soo Lee Korea Research and Care Practice for Mood Disorder in Korea

6/5 F 1605 1735 Symposium 26 Speaker3 SY26-3 Roger NG Hong Kong Mental imagery in bipolar disorders: research implications on CBT for bipolar disorders

6/5 F 1605 1735 Symposium 26 Speaker4 SY26-4 Takeshi Inoue Japan Interaction between personality, childhood abuse, and adult life events on depression

TBA

Subspeciality education in Psychiatry

Development and challenges of education, training and board certification in the region

Integrating Care: Mental Health as a Global Imperative

Opportunities and Challenges in Psychiatric Education

Perspectives on research and care practice for mood disorder





Shigenobu Kanba Japan

6/5 F 1745 1915 Symposium 31 Co-chair Tsuyoshi Akiyama Japan

6/5 F 1745 1915 Symposium 31 Speaker1 SY31-1 Tahilia Rebello USA THE ROLE OF FIELD TRIALS IN DEVELOPING ICD-11

6/5 F 1745 1915 Symposium 31 Speaker2 SY31-2 Jared Keeley USA Case-controlled field studies for ICD-11 Mental and Behavioural Disorders

6/5 F 1745 1915 Symposium 31 Speaker3 SY31-3 Pratap Sharan India Ecological implementation field studies for ICD-11 Mental and Behavioural Disorders

6/5 F 1745 1915 Symposium 31 Speaker4 SY31-4 Toshimasa Maruta Japan Contribution from Japan to the development of the ICD-11

6/5 K 0800 0930 Leaders Round Table 2 Chair Helen Herrman Australia

6/5 K 0800 0930 Leaders Round Table 2 Co-chair Tsuyoshi Akiyama Japan

6/5 K 0800 0930 Leaders Round Table 2 Speaker1 LR2-1 Linda Lam Hong Kong

6/5 K 0800 0930 Leaders Round Table 2 Speaker2 LR2-2 Min-Soo Lee Korea

6/5 K 0800 0930 Leaders Round Table 2 Speaker3 LR2-3 Frank Huang Chih Chou Taiwan

6/5 K 0800 0930 Leaders Round Table 2 Speaker4 LR2-4 Masatoshi Takeda Japan

6/5 K 0800 0930 Leaders Round Table 2 Speaker5 LR2-5 Pichet Udomratn Thailand

6/5 K 0800 0930 Leaders Round Table 2 Speaker6 LR2-6 Roy Abraham Kallivayalil India

6/5 K 0800 0930 Leaders Round Table 2 Speaker7 LR2-7 Afzal Javed Pakistan

6/5 K 0800 0930 Leaders Round Table 2 Speaker8 LR2-8 Paul Summergrad USA

6/5 K 0800 0930 Leaders Round Table 2 Speaker9 LR2-9 Malcolm Hopwood Australia

6/5 K 0800 0930 Leaders Round Table 2 Concluding Remark Dinesh Bhugra UK

6/5 K 0940 1110 Symposium 20 CoordinatorChair

Susumu Higuchi Japan

6/5 K 0940 1110 Symposium 20 Speaker1 SY20-1 Satoko Mihara Japan Epidemiological Findings of Internet Use Disorder

6/5 K 0940 1110 Symposium 20 Speaker2 SY20-2 Sung-won Roh Korea Something in Common between Internet and Substance: Neuroimaging Aspects

6/5 K 0940 1110 Symposium 20 Speaker3 SY20-3 Hae-Kook Lee Korea Internet addiction : Is it unique phenomenon of disease ?

6/5 K 0940 1110 Symposium 20 Speaker4 SY20-4 Hideki Nakayama Japan The course and treatment response of Internet use disorder

6/5 K 1120 1205 Special Lecture 5 Chair Shigenobu Kanba Japan

6/5 K 1120 1205 Special Lecture 5 Speaker SL5-1 Pratap Sharan India Latest developments in ICD-11 Mental and Behavioural Disorders

Development of revised criteria for the classification of mental disorders in the ICD-11

Report from Asian countries: Message from psychiatry in Asia and Pacific: achievements and challenges for psychiatry in my country

Recent development in the disease concept and diagnostic guidelines of Internet use disorder

Latest developments in ICD-11 Mental and Behavioural Disorders





Jotaro Akiyoshi Japan

6/5 K 1425 1555 Symposium 22 Co-chair Takeshi Inoue Japan

6/5 K 1425 1555 Symposium 22 Speaker1 SY22-1 Sakie Shimotsu Japan Self-stigma in patients with depressive and anxiety symptoms

6/5 K 1425 1555 Symposium 22 Speaker2 SY22-2 Jotaro Akiyoshi Japan Relationship between affective, anxiety disorders, salivary amylase, brain volume, genetic variation

6/5 K 1425 1555 Symposium 22 Speaker3 SY22-3 Yoko Kamio Japan Developmental trajectories of anxiety symptoms in childhood

6/5 K 1425 1555 Symposium 22 Speaker4 SY22-4 Edmond Pi USA Recent Advances in the Treatment of Depression: A Cross-cultural Perspective


Dinesh Bhugra UK

6/5 K 1605 1735 Symposium 27 Speaker SY27-1 Dinesh Bhugra UK

6/5 K 1605 1735 Symposium 27 Speaker SY27-2 Helen Herrman Australia

6/5 K 1605 1735 Symposium 27 Speaker SY27-3 Roy Abraham Kallivayalil India

6/5 K 1605 1735 Symposium 27 Speaker SY27-4 Edgard Belfort Venezuela

6/5 K 1605 1735 Symposium 27 Speaker SY27-5 Armen Soghoyan Armenia

6/5 K 1605 1735 Symposium 27 Speaker SY27-6 Masatoshi Takeda Japan

6/5 K 1605 1735 Symposium 27 Speaker SY27-7 Michelle Riba USA

6/5 K 1605 1735 Symposium 27 Speaker SY27-8 Afzal Javed Pakistan


Hiroshi Matsuda Japan

6/5 K 1745 1915 Symposium 32 Co-chair Hitoshi Miyaoka Japan

6/5 K 1745 1915 Symposium 32 Speaker1 SY32-1 Andri Andri Indonesia Review of Indonesia Psychiatric Treatment Condition : Different Perspective of Public and Private Service

6/5 K 1745 1915 Symposium 32 Speaker2 SY32-2 Edgard Belfort Venezuela Progress and of Challenge for Services provided by Psychiatric Hospitals: The reality of the management of mental health services in Latin America

6/5 K 1745 1915 Symposium 32 Speaker3 SY32-3 Manabu Yamazaki Japan TBA

6/5 L 0940 1110 Fellowship Award Symposium 3

CoordinatorChair

Dinesh Bhugra UK


Co-chair Toshitaka Ii Japan


Speaker1 FS3-1 Sifat E-Syed Bangladesh BANGLADESH CASE VIGNETTE


Speaker2 FS3-2 Ekaterine Berdzenishvili Georgia Psychiatry and Crime: Georgian Pathway


Speaker3 FS3-3 Katarina Ceranic Ninic Slovenia Schizophrenia and criminal offence case report


Speaker4 FS3-4 Kiyoshi Takao Japan Psychiatric evaluation with Medical Treatment and Supervision Act in Japan

6/5 L 1120 1205 Special Lecture 6 Chair TBA

6/5 L 1120 1205 Special Lecture 6 Speaker SL6-1 Sue Bailey UK Progress for Parity in Practice for Mental Health a UK perspective

Challenges Facing Psychiatric Treatment in Asia : The Current Status and Issues

Forensic psychiatryⅠ: From the view of the psychiatry

Progress for Parity in Practice for Mental Health a UK perspective

How is stress related to onset, treatment and prognosis in major depressive and anxiety disorders?

WPA ForumQuestions　& Answers Session with WPA EC members




6/5 L 1425 1555 Symposium 23 CoordinatorChair

Yoshio Igarashi Japan

6/5 L 1425 1555 Symposium 23 Co-chair Asako Sanae Japan

6/5 L 1425 1555 Symposium 23 Speaker1 SY23-1 Kazuhiro Uenoyama Japan The Japanese psychiatric care system from the perspective of psychiatric clinics

6/5 L 1425 1555 Symposium 23 Speaker2 SY23-2 Keizo Hara Japan The report of mental support activity in the disaster area after the Eastern Japan Great Earthquake

6/5 L 1425 1555 Symposium 23 Speaker3 SY23-3 Eun-Soo Won Korea Psychiatric Outpatient Treatment in Korea

6/5 L 1425 1555 Symposium 23 Speaker4 SY23-4 Ming-Wei Huang Taiwan The Psychiatric Outpatient Care in Taiwan

6/5 L 1605 1735 Symposium 28 CoordinatorChair

Wai Kwong Tang Hong Kong

6/5 L 1605 1735 Symposium 28 Co-chair Susumu Higuchi Japan

6/5 L 1605 1735 Symposium 28 Speaker1 SY28-1 Wai Kwong Tang Hong Kong Evidence of Brain Damage in Chronic Ketamine Users.

6/5 L 1605 1735 Symposium 28 Speaker2 SY28-2 Kenji Hashimoto Japan BDNF-TrkB signaling as a potential therapeutic target for methamphetamine abuse

6/5 L 1605 1735 Symposium 28 Speaker3 SY28-3 Zhimin Liu China Investigation of the Situation of Drug Abuse and Evaluation of the Scale of Drug Users in 14 Cities in China

6/5 L 1605 1735 Symposium 28 Speaker4 SY28-4 Kazutaka Ikeda Japan Genetic mechanisms underlying individual differences in opioid sensitivity in Japanese


CoordinatorChair

Wolfgang Gaebel Germany


Co-chair Toshitaka Ii Japan


Speaker1 FS4-1 Chung Hin Willy Wong Hong Kong Case Vignette:Describe how you would deal with the following case:


Speaker2 FS4-2 Giacomo Grassi Italy Management of a psychotic onset in an Italian hospital


Speaker3 FS4-3 Howard Ryland UK The forensic mental health pathway in England and Wales: The interaction been national legislation and specialised services.


Speaker4 FS4-4 Hiroko Kashiwagi Japan The pathway for forensic psychiatric cases in Japan which involve a serious offence, with a focus on the Medical Treatment and Supervision Act

6/5 M 1425 1555 Symposium 24 CoordinatorChair

Masato Fukuda Japan

6/5 M 1425 1555 Symposium 24 Co-chair Toshiya Murai Japan

6/5 M 1425 1555 Symposium 24 Speaker1 SY24-1 Jun Miyata Japan Abnormal Functional Connectivity on the Trajectory of Psychosis

6/5 M 1425 1555 Symposium 24 Speaker2 SY24-2 Sung Nyun Kim Korea MRI study of schizophrenia in Korea (tentative)

6/5 M 1425 1555 Symposium 24 Speaker3 SY24-3 Shinsuke Koike Japan Present and future neuroimaging studies for psychosis spectrum in Japan

6/5 M 1425 1555 Symposium 24 Speaker4 SY24-4 Xijin Wang China Disrupted Resting-State Functional Connectivity in Minimally Treated Chronic Schizophrenia


Heii Arai Japan

6/5 M 1605 1735 Symposium 29 Speaker1 SY29-1 Heii Arai Japan Overview of the symposium

6/5 M 1605 1735 Symposium 29 Speaker2 SY29-2 Lon Schneider USA APA treatment guidelines, FDA guidelines, and drug development for Alzheimer disease

6/5 M 1605 1735 Symposium 29 Speaker3 SY29-3 Mieko Otsuka Japan Association between dietary patterns and risk and prevention of dementia patient in Japan

6/5 M 1605 1735 Symposium 29 Speaker4 SY29-4 Tohru Ohnuma Japan The benefit and intolerance in use of medium chain triglycerides for Alzheimer's disease in Japan

In pursuit of inter-Asia MRI collaborations

Parmacological and neutritional approaches for people with Alzheimer's disease

Vision of psychiatric outpatient clinic

Psychotropic drug abuse in Asia

Forensic psychiatryⅡ: From the view of the law





Masafumi Mizuno Japan

6/5 M 1745 1915 Symposium 33 Co-chair Michio Suzuki Japan

6/5 M 1745 1915 Symposium 33 Speaker1 SY33-1 Helen Herrman Australia Early intervention as a priority for world psychiatry

6/5 M 1745 1915 Symposium 33 Speaker2 SY33-2 Atsushi Nishida Japan Promoting physical health of young people with psychosis in Japan: HeAL-Japan Initiative

6/5 M 1745 1915 Symposium 33 Speaker3 SY33-3 Kazunori Matsumoto Japan Challenge of introducing and disseminating early intervention to people with ARMS in Japan

6/5 M 1745 1915 Symposium 33 Speaker4 SY33-4 Takahiro Nemoto Japan Clinical practice at a multi-dimensional treatment center for early psychosis in Central Tokyo

6/5 N 1425 1555 Symposium 25 CoordinatorChair

Tadashi Takeshima Japan

6/5 N 1425 1555 Symposium 25 Co-chair Frank Huang Chih Chou Taiwan

6/5 N 1425 1555 Symposium 25 Speaker1 SY25-1 Sachio Matsushita Japan Epidemiologic studies on alcohol and the Basic Act for Measures against Alcohol-related Health Harm

6/5 N 1425 1555 Symposium 25 Speaker2 SY25-2 Tsuyoshi Okamura Japan Homeless people with mental illness in Japan

6/5 N 1425 1555 Symposium 25 Speaker3 SY25-3 Takashi Yamauchi Japan Epidemiological studies on fatal/non-fatal suicidal behavior and suicide prevention policy in Japan

6/5 N 1425 1555 Symposium 25 Speaker4 SY25-4 Wei Jen Chen Taiwan Development of Suicide Prevention Research of Kaohsiung City in Taiwan

6/5 N 1605 1735 Symposium 30 Coordinator Tadashi Takeshima Japan

6/5 N 1605 1735 Symposium 30 Chair Daisuke Nishi Japan

6/5 N 1605 1735 Symposium 30 Co-chair Yuriko Suzuki Japan

6/5 N 1605 1735 Symposium 30 Speaker1 SY30-1 Yuriko Suzuki Japan Kokoro-no care for school children after the Great East Japan Earthquake in Sendai city

6/5 N 1605 1735 Symposium 30 Speaker2 SY30-2 Daisuke Nishi Japan Mental health epidemiology in injured patients

6/5 N 1605 1735 Symposium 30 Speaker3 SY30-3 Asuka Koyama Japan Epidemiological studies on mental health among the elderly

6/5 N 1605 1735 Symposium 30 Speaker4 SY30-4 Jong-Woo Paik Korea Epidemiological studies on mental health and suicide in South Korea

6/5 N 1745 1915 Symposium 34 CoordinatorChair

Yong Sik Kim Korea

6/5 N 1745 1915 Symposium 34 Co-chair Toshiya Inada Japan

6/5 N 1745 1915 Symposium 34 Speaker1 SY34-1 Toshiya Inada Japan The DIEPSS: beyond the Eurasian Continent and the Pacific Ocean

6/5 N 1745 1915 Symposium 34 Speaker2 SY34-2 Ken Inada Japan Importance of evaluating EPS in clinical trials for the next generation of non-dopaminergic agents

6/5 N 1745 1915 Symposium 34 Speaker3 SY34-3 Yong Sik Kim Korea The subjective experience of drug induced EPS and their interaction with psychopathology

6/5 N 1745 1915 Symposium 34 Speaker4 SY34-4 Jun Horiguchi Japan Neuroleptic-induced extrapyramidal symptoms and the treatment in clinical practice

Early Intervention in Psychiatry: Steps for Tomorrow

Mental health epidemiology for policy development regarding mental health issues

Mental health epidemiology for various populations

How to understand Drug-induced Extrapyramidal Symptom in the era of second generation antipsychotics

wpa2015 lecture / symposium

Documents